Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reissued by investment analysts at Peel Hunt in a research report issued to clients and investors on Thursday.

A number of other research analysts have also recently commented on SPI. Berenberg Bank cut Spire Healthcare Group to a “sell” rating and decreased their price target for the stock from GBX 290 ($3.79) to GBX 120 ($1.57) in a research note on Wednesday, August 8th. Credit Suisse Group upgraded Spire Healthcare Group to a “neutral” rating and decreased their price target for the stock from GBX 250 ($3.27) to GBX 215 ($2.81) in a research note on Wednesday, August 8th. Jefferies Financial Group cut Spire Healthcare Group to a “hold” rating and decreased their price target for the stock from GBX 290 ($3.79) to GBX 160 ($2.09) in a research note on Friday, August 10th. Liberum Capital restated a “hold” rating on shares of Spire Healthcare Group in a research note on Friday, August 24th. Finally, Barclays cut Spire Healthcare Group to an “underweight” rating and reduced their price objective for the company from GBX 190 ($2.48) to GBX 130 ($1.70) in a research note on Friday, September 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company’s stock. Spire Healthcare Group currently has an average rating of “Hold” and a consensus price target of GBX 189 ($2.47).

LON:SPI opened at GBX 105.80 ($1.38) on Thursday. Spire Healthcare Group has a 52 week low of GBX 206.40 ($2.70) and a 52 week high of GBX 362.10 ($4.73).

In other Spire Healthcare Group news, insider Adèle Anderson bought 9,582 shares of the company’s stock in a transaction that occurred on Friday, September 21st. The shares were purchased at an average price of GBX 155 ($2.03) per share, with a total value of £14,852.10 ($19,406.90). Also, insider Jitesh Himatlal Sodha bought 50,500 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was acquired at an average cost of GBX 147 ($1.92) per share, for a total transaction of £74,235 ($97,001.18). Over the last quarter, insiders bought 260,082 shares of company stock worth $35,308,710.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Further Reading: Investing in Growth Stocks

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.